Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Blood Specimen Collection × Clear all

Phase

Status

Recruiting 3 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Glioblastoma 2 Carcinoma, Hepatocellular 2 Vascular Malformations 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Obesity 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hodgkin Disease 1 Hemangioma, Capillary 1

Interventions

Cyclophosphamide 11 fludarabine 8 aldesleukin 8 fludarabine phosphate 6 pembrolizumab 5 Nivolumab 4 Ipilimumab 4 Interleukin-2 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03603587 2020-03-05

BACCHUS

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡